|
stem cell differentiation
|
GO:0048863 |
268 |
0.510
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.506
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.459
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.444
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.385
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.348
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.344
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.321
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.299
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.297
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.263
|
|
|
histone modification
|
GO:0016570 |
159 |
0.257
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.247
|
|
|
midbrain hindbrain boundary morphogenesis
|
GO:0021555 |
4 |
0.233
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.226
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.226
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.221
|
|
|
positive regulation of transcription elongation from rna polymerase ii promoter
|
GO:0032968 |
2 |
0.219
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.165
|
|
|
metanephric capsule specification
|
GO:0072267 |
1 |
0.156
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.151
|
|
|
protein processing
|
GO:0016485 |
163 |
0.144
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.142
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.139
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.134
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.133
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.131
|
|
|
gland development
|
GO:0048732 |
330 |
0.130
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.125
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.117
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.116
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.113
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.111
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.109
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.104
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.103
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.103
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.100
|
|
|
ectoderm formation
|
GO:0001705 |
3 |
0.098
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.098
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.096
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.095
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.093
|
|
|
tube closure
|
GO:0060606 |
91 |
0.089
|
|
|
olfactory lobe development
|
GO:0021988 |
32 |
0.088
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.087
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.083
|
|
|
positive regulation of transcription via serum response element binding
|
GO:0010735 |
1 |
0.082
|
|
|
commitment of multipotent stem cells to neuronal lineage in forebrain
|
GO:0021898 |
3 |
0.082
|
|
|
regulation of endodermal cell differentiation
|
GO:1903224 |
2 |
0.080
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.080
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.078
|
|
|
neurohypophysis development
|
GO:0021985 |
2 |
0.077
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.075
|
|
|
wound healing
|
GO:0042060 |
157 |
0.075
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.074
|
|
|
ossification
|
GO:0001503 |
216 |
0.073
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.072
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.071
|
|
|
regionalization
|
GO:0003002 |
337 |
0.068
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.068
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.068
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.067
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.067
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.067
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.066
|
|
|
regulation of transcription involved in primary germ layer cell fate commitment
|
GO:0060796 |
2 |
0.065
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.065
|
|
|
heparin biosynthetic process
|
GO:0030210 |
2 |
0.064
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.064
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.064
|
|
|
gonad morphogenesis
|
GO:0035262 |
1 |
0.063
|
|
|
tube formation
|
GO:0035148 |
140 |
0.063
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.063
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.063
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.062
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.062
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.062
|
|
|
positive regulation of hh target transcription factor activity
|
GO:0007228 |
3 |
0.060
|
|
|
nodal signaling pathway involved in determination of lateral mesoderm left right asymmetry
|
GO:1900164 |
2 |
0.060
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.060
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.058
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.058
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.058
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.057
|
|
|
locus ceruleus development
|
GO:0021703 |
1 |
0.057
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.057
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.056
|
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.056
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.054
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.054
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
28 |
0.054
|
|
|
ear development
|
GO:0043583 |
200 |
0.054
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.054
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.054
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.053
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.053
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.052
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.052
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.052
|
|
|
protein import
|
GO:0017038 |
101 |
0.051
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.050
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.048
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.048
|
|
|
regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:0072039 |
4 |
0.048
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.048
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.048
|
|
|
auditory receptor cell fate determination
|
GO:0042668 |
3 |
0.048
|
|
|
rhombomere morphogenesis
|
GO:0021593 |
2 |
0.047
|
|
|
nodal signaling pathway involved in determination of left right asymmetry
|
GO:0038107 |
2 |
0.046
|
|
|
mitochondrion localization
|
GO:0051646 |
9 |
0.046
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.046
|
|
|
embryonic heart tube formation
|
GO:0003144 |
1 |
0.044
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.043
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.042
|
|
|
pyramidal neuron migration
|
GO:0021852 |
1 |
0.042
|
|
|
blastocyst growth
|
GO:0001832 |
23 |
0.042
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.041
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.041
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.041
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.041
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.041
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.040
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.040
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.040
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.040
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.040
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.039
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.039
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.038
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.038
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.038
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.038
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.038
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.037
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.037
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.036
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.036
|
|
|
gonad development
|
GO:0008406 |
141 |
0.036
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.036
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.036
|
|
|
protein localization to chromatin
|
GO:0071168 |
3 |
0.036
|
|
|
olfactory nerve development
|
GO:0021553 |
3 |
0.036
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.036
|
|
|
regulation of endodermal cell fate specification
|
GO:0042663 |
2 |
0.035
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.035
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.034
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.034
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.034
|
|
|
embryonic olfactory bulb interneuron precursor migration
|
GO:0021831 |
2 |
0.034
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.034
|
|
|
histone h4 k12 acetylation
|
GO:0043983 |
2 |
0.033
|
|
|
histone h3 k14 acetylation
|
GO:0044154 |
3 |
0.033
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.033
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.033
|
|
|
trophectodermal cellular morphogenesis
|
GO:0001831 |
3 |
0.033
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.033
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.033
|
|
|
protein palmitoylation
|
GO:0018345 |
14 |
0.032
|
|
|
positive regulation of auditory receptor cell differentiation
|
GO:0045609 |
1 |
0.032
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.032
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.032
|
|
|
astrocyte differentiation
|
GO:0048708 |
43 |
0.032
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.032
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.032
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.032
|
|
|
forebrain neuron fate commitment
|
GO:0021877 |
13 |
0.032
|
|
|
astrocyte development
|
GO:0014002 |
12 |
0.031
|
|
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000802 |
1 |
0.031
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.030
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.030
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.030
|
|
|
exocrine pancreas development
|
GO:0031017 |
7 |
0.030
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.030
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.030
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.029
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.029
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.029
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.028
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.028
|
|
|
neuroblast fate commitment
|
GO:0014017 |
1 |
0.028
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.028
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.028
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.028
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.028
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.027
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.027
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.027
|
|
|
cloacal septation
|
GO:0060197 |
2 |
0.027
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.026
|
|
|
growth plate cartilage chondrocyte growth
|
GO:0003430 |
2 |
0.026
|
|
|
secondary heart field specification
|
GO:0003139 |
6 |
0.026
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.026
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.025
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.025
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.025
|
|
|
dna replication
|
GO:0006260 |
52 |
0.025
|
|
|
positive regulation of chromosome segregation
|
GO:0051984 |
4 |
0.025
|
|
|
embryonic genitalia morphogenesis
|
GO:0030538 |
4 |
0.025
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.025
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.025
|
|
|
middle ear morphogenesis
|
GO:0042474 |
23 |
0.025
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.025
|
|
|
ribonucleoprotein complex subunit organization
|
GO:0071826 |
28 |
0.024
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.024
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.024
|
|
|
regulation of astrocyte differentiation
|
GO:0048710 |
20 |
0.024
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.024
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.024
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.024
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.024
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.024
|
|
|
post embryonic retina morphogenesis in camera type eye
|
GO:0060060 |
3 |
0.024
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.024
|
|
|
otolith morphogenesis
|
GO:0032474 |
3 |
0.024
|
|
|
pronephric field specification
|
GO:0039003 |
2 |
0.024
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.024
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.024
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.024
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.023
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.023
|
|
|
commitment of neuronal cell to specific neuron type in forebrain
|
GO:0021902 |
7 |
0.023
|
|
|
glomerular mesangial cell differentiation
|
GO:0072008 |
3 |
0.023
|
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
43 |
0.023
|
|
|
regulation of cellular ketone metabolic process by regulation of transcription from rna polymerase ii promoter
|
GO:0072364 |
7 |
0.023
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.023
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.023
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.023
|
|
|
organism emergence from protective structure
|
GO:0071684 |
4 |
0.023
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.023
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.023
|
|
|
thymus development
|
GO:0048538 |
41 |
0.023
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.023
|
|
|
regulation of smoothened signaling pathway
|
GO:0008589 |
58 |
0.023
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.022
|
|
|
sensory neuron axon guidance
|
GO:0097374 |
3 |
0.022
|
|
|
methylation
|
GO:0032259 |
134 |
0.022
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.022
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.022
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.022
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.022
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.022
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.022
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.022
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.022
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.022
|
|
|
rna interference
|
GO:0016246 |
2 |
0.022
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.022
|
|
|
regulation of transcription by chromatin organization
|
GO:0034401 |
0 |
0.022
|
|
|
epithalamus development
|
GO:0021538 |
2 |
0.021
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.021
|
|
|
trophectodermal cell differentiation
|
GO:0001829 |
21 |
0.021
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.021
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.021
|
|
|
maturation of 5 8s rrna
|
GO:0000460 |
1 |
0.021
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.021
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.021
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.020
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.020
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.020
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.020
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.020
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process
|
GO:2000763 |
1 |
0.020
|
|
|
globus pallidus development
|
GO:0021759 |
2 |
0.020
|
|
|
oculomotor nerve morphogenesis
|
GO:0021622 |
2 |
0.020
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.020
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.020
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.020
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.020
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.020
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.020
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.020
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.020
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.019
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
38 |
0.019
|
|
|
branching involved in mammary gland duct morphogenesis
|
GO:0060444 |
27 |
0.019
|
|
|
regulation of dna binding
|
GO:0051101 |
39 |
0.019
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.019
|
|
|
establishment of vesicle localization
|
GO:0051650 |
81 |
0.019
|
|
|
signal transduction downstream of smoothened
|
GO:0007227 |
4 |
0.019
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.019
|
|
|
positive regulation of mechanoreceptor differentiation
|
GO:0045633 |
1 |
0.019
|
|
|
cell division
|
GO:0051301 |
120 |
0.019
|
|
|
gastrulation with mouth forming second
|
GO:0001702 |
29 |
0.019
|
|
|
activin receptor signaling pathway
|
GO:0032924 |
18 |
0.019
|
|
|
regulation of gastrulation
|
GO:0010470 |
16 |
0.019
|
|
|
central nervous system segmentation
|
GO:0035283 |
3 |
0.019
|
|
|
bone development
|
GO:0060348 |
120 |
0.018
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.018
|
|
|
rrna transcription
|
GO:0009303 |
9 |
0.018
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.018
|
|
|
embryonic heart tube anterior posterior pattern specification
|
GO:0035054 |
3 |
0.018
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.018
|
|
|
motor neuron migration
|
GO:0097475 |
4 |
0.018
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.018
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
52 |
0.018
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.018
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.018
|
|
|
dna templated transcription elongation
|
GO:0006354 |
13 |
0.018
|
|
|
palate development
|
GO:0060021 |
76 |
0.018
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.018
|
|
|
endochondral bone growth
|
GO:0003416 |
19 |
0.018
|
|
|
negative regulation of photoreceptor cell differentiation
|
GO:0046533 |
4 |
0.018
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.018
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.018
|
|
|
neural tube patterning
|
GO:0021532 |
43 |
0.017
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.017
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
47 |
0.017
|
|
|
kidney mesenchymal cell proliferation
|
GO:0072135 |
2 |
0.017
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.017
|
|
|
nls bearing protein import into nucleus
|
GO:0006607 |
2 |
0.017
|
|
|
trachea formation
|
GO:0060440 |
3 |
0.017
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.017
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.017
|
|
|
histone h4 acetylation
|
GO:0043967 |
10 |
0.017
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.017
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.016
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.016
|
|
|
spinal cord dorsal ventral patterning
|
GO:0021513 |
23 |
0.016
|
|
|
positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090100 |
43 |
0.016
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.016
|
|
|
regulation of g protein coupled receptor protein signaling pathway
|
GO:0008277 |
37 |
0.016
|
|
|
amide transport
|
GO:0042886 |
138 |
0.016
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.016
|
|
|
inner ear receptor cell differentiation
|
GO:0060113 |
61 |
0.016
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.016
|
|
|
regulation of rna splicing
|
GO:0043484 |
37 |
0.016
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.016
|
|
|
cerebellar granule cell precursor proliferation
|
GO:0021930 |
10 |
0.016
|
|
|
negative regulation of gastrulation
|
GO:2000542 |
3 |
0.016
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.016
|
|
|
cell fate commitment involved in formation of primary germ layer
|
GO:0060795 |
26 |
0.016
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.016
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.016
|
|
|
dna biosynthetic process
|
GO:0071897 |
22 |
0.016
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.016
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.016
|
|
|
regulation of vascular wound healing
|
GO:0061043 |
2 |
0.016
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.015
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.015
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.015
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.015
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.015
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
35 |
0.015
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.015
|
|
|
regulation of apoptotic process involved in outflow tract morphogenesis
|
GO:1902256 |
2 |
0.015
|
|
|
negative regulation of binding
|
GO:0051100 |
39 |
0.015
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.015
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.015
|
|
|
atrioventricular bundle cell differentiation
|
GO:0003167 |
1 |
0.015
|
|
|
embryonic nail plate morphogenesis
|
GO:0035880 |
3 |
0.015
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.015
|
|
|
efferent axon development in a lateral line nerve
|
GO:0048894 |
1 |
0.015
|
|
|
zygotic determination of anterior posterior axis embryo
|
GO:0007354 |
3 |
0.015
|
|
|
cleavage involved in rrna processing
|
GO:0000469 |
1 |
0.015
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.015
|
|
|
renal system development
|
GO:0072001 |
225 |
0.015
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.015
|
|
|
chromatin remodeling
|
GO:0006338 |
32 |
0.015
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.014
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.014
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.014
|
|
|
cell proliferation in external granule layer
|
GO:0021924 |
10 |
0.014
|
|
|
heart trabecula morphogenesis
|
GO:0061384 |
26 |
0.014
|
|
|
mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:1901145 |
4 |
0.014
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.014
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.014
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.014
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.014
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.014
|
|
|
ductus arteriosus closure
|
GO:0097070 |
3 |
0.014
|
|
|
regulation of cell fate commitment
|
GO:0010453 |
19 |
0.014
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.014
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.014
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.014
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.014
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.014
|
|
|
positive regulation of synaptic growth at neuromuscular junction
|
GO:0045887 |
1 |
0.014
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.014
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation
|
GO:0003257 |
3 |
0.014
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.014
|
|
|
smoothened signaling pathway involved in spinal cord motor neuron cell fate specification
|
GO:0021776 |
3 |
0.014
|
|
|
cranial nerve formation
|
GO:0021603 |
4 |
0.014
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.014
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.014
|
|
|
nucleobase biosynthetic process
|
GO:0046112 |
3 |
0.014
|
|
|
cell cycle checkpoint
|
GO:0000075 |
47 |
0.014
|
|
|
negative regulation of t cell proliferation
|
GO:0042130 |
38 |
0.014
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.014
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.014
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.014
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.014
|
|
|
frontal suture morphogenesis
|
GO:0060364 |
2 |
0.014
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.013
|
|
|
hindbrain formation
|
GO:0021576 |
1 |
0.013
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.013
|
|
|
regulation of transcription during meiosis
|
GO:0051037 |
1 |
0.013
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.013
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.013
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.013
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.013
|
|
|
stem cell fate specification
|
GO:0048866 |
3 |
0.013
|
|
|
axial mesoderm formation
|
GO:0048320 |
3 |
0.013
|
|
|
face morphogenesis
|
GO:0060325 |
29 |
0.013
|
|
|
response to muscle stretch
|
GO:0035994 |
1 |
0.013
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.013
|
|
|
rhombomere 2 development
|
GO:0021568 |
2 |
0.013
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.013
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.013
|
|
|
transcription coupled nucleotide excision repair
|
GO:0006283 |
2 |
0.013
|
|
|
nuclear membrane organization
|
GO:0071763 |
4 |
0.013
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.013
|
|
|
hindbrain tangential cell migration
|
GO:0021934 |
2 |
0.013
|
|
|
axial mesodermal cell differentiation
|
GO:0048321 |
1 |
0.013
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.013
|
|
|
mammary gland specification
|
GO:0060594 |
4 |
0.013
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.013
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.013
|
|
|
rhombomere 5 development
|
GO:0021571 |
4 |
0.013
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.013
|
|
|
regulation of auditory receptor cell differentiation
|
GO:0045607 |
4 |
0.013
|
|
|
neural retina development
|
GO:0003407 |
41 |
0.013
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.012
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.012
|
|
|
growth plate cartilage chondrocyte proliferation
|
GO:0003419 |
3 |
0.012
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.012
|
|
|
hindbrain morphogenesis
|
GO:0021575 |
46 |
0.012
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.012
|
|
|
response to sterol
|
GO:0036314 |
4 |
0.012
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.012
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.012
|
|
|
tolerance induction to self antigen
|
GO:0002513 |
4 |
0.012
|
|
|
maturation of 5 8s rrna from tricistronic rrna transcript ssu rrna 5 8s rrna lsu rrna
|
GO:0000466 |
1 |
0.012
|
|
|
positive regulation of myeloid leukocyte differentiation
|
GO:0002763 |
26 |
0.012
|
|
|
organ growth
|
GO:0035265 |
117 |
0.012
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.012
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.012
|
|
|
positive regulation of nucleocytoplasmic transport
|
GO:0046824 |
30 |
0.012
|
|
|
ureter urothelium development
|
GO:0072190 |
3 |
0.012
|
|
|
chromatin assembly
|
GO:0031497 |
13 |
0.012
|
|
|
regulation of mast cell differentiation
|
GO:0060375 |
3 |
0.012
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.012
|
|
|
skin development
|
GO:0043588 |
220 |
0.012
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.012
|
|
|
histone lysine demethylation
|
GO:0070076 |
13 |
0.012
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.012
|
|
|
regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000800 |
1 |
0.012
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.012
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.012
|
|
|
peripheral nervous system neuron axonogenesis
|
GO:0048936 |
3 |
0.012
|
|
|
peptidyl arginine omega n methylation
|
GO:0035247 |
2 |
0.012
|
|
|
regulation of mesenchymal cell proliferation involved in ureter development
|
GO:0072199 |
3 |
0.012
|
|
|
hair cell differentiation
|
GO:0035315 |
40 |
0.012
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.012
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.012
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.012
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.012
|
|
|
ncrna processing
|
GO:0034470 |
26 |
0.012
|
|
|
chromatin assembly or disassembly
|
GO:0006333 |
16 |
0.011
|
|
|
positive regulation of transcription from rna polymerase i promoter
|
GO:0045943 |
3 |
0.011
|
|
|
g0 to g1 transition
|
GO:0045023 |
3 |
0.011
|
|
|
rna splicing via transesterification reactions with bulged adenosine as nucleophile
|
GO:0000377 |
43 |
0.011
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.011
|
|
|
cell proliferation in forebrain
|
GO:0021846 |
30 |
0.011
|
|
|
inner cell mass cell differentiation
|
GO:0001826 |
7 |
0.011
|
|
|
neural crest cell migration involved in autonomic nervous system development
|
GO:1901166 |
5 |
0.011
|
|
|
metanephric dct cell differentiation
|
GO:0072240 |
3 |
0.011
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.011
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.011
|
|
|
facial nucleus development
|
GO:0021754 |
2 |
0.011
|
|
|
inner cell mass cell proliferation
|
GO:0001833 |
15 |
0.011
|
|
|
positive regulation of intracellular protein transport
|
GO:0090316 |
42 |
0.011
|
|
|
neural crest cell development
|
GO:0014032 |
48 |
0.011
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
60 |
0.011
|
|
|
signal transduction involved in mitotic g1 dna damage checkpoint
|
GO:0072431 |
3 |
0.011
|
|
|
positive regulation of dna binding
|
GO:0043388 |
14 |
0.011
|
|
|
regulation of gluconeogenesis by regulation of transcription from rna polymerase ii promoter
|
GO:0035947 |
7 |
0.011
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.011
|
|
|
epidermal cell fate specification
|
GO:0009957 |
1 |
0.011
|
|
|
pyrimidine nucleobase metabolic process
|
GO:0006206 |
3 |
0.011
|
|